Cover Image

Correction to: Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience

Saved in:

Bibliographic Details
Main Authors:	Shinya Tsuboi (Author), Tatsuya Hayama (Author), Katsuhiro Miura (Author), Akihiro Uchiike (Author), Daisuke Tsutsumi (Author), Takashi Yamauchi (Author), Yoshihiro Hatta (Author), Susumu Ootsuka (Author)
Format:	Book
Published:	BMC, 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience
by: Shinya Tsuboi, et al.
Published: (2023)

Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
by: Akihiro Uchiike, et al.
Published: (2023)

Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study
by: Rossi L, et al.
Published: (2013)

Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to Pegfilgrastim
by: Henriette Kuehne, et al.
Published: (2024)

Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta® in healthy subjects: A randomized, double‐blind trial
by: Chris Wynne, et al.
Published: (2020)

Pharmacodynamics, safety, and immunogenicity of Pelmeg®, a pegfilgrastim biosimilar in healthy subjects
by: Hendrik Wessels, et al.
Published: (2019)

Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review
by: Girma Tekle Gebremariam, et al.
Published: (2022)

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg®, a pegfilgrastim biosimilar in healthy subjects
by: Karsten Roth, et al.
Published: (2019)

Ginsenoside Rg3 for Chemotherapy-Induced Myelosuppression: A Meta-Analysis and Systematic Review
by: Linlin Pan, et al.
Published: (2020)

Cost-Utility Analysis of Lipegfilgrastim Compared to Pegfilgrastim for the Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Stage II-IV Breast Cancer
by: Esse I. H. Akpo, et al.
Published: (2017)

Promotion of myelopoiesis in myelosuppressed mice by Ganoderma lucidum polysaccharides
by: Xiao Ling Zhu, et al.
Published: (2012)

Health professionals' preferences with the use of pegfilgrastim on-body injector at oncology centers in 8 cities in Colombia
by: María Alejandra Larrarte-González, et al.
Published: (2023)

Uso do dispositivo Pegfilgrastim OBI para prevenção de neutropenia: revisão de escopo
by: Vivian do Prado Martins, et al.
Published: (2023)

Carbohydrates and ginsenosides in shenmai injection jointly improve hematopoietic function during chemotherapy-induced myelosuppression in mice
by: Shiyu Zhang, et al.
Published: (2022)

Localized Pegfilgrastim-induced Neutrophilic Dermatosis with Tissue G-CSF Expression: A Mimicker of Sweet's Syndrome
by: Toshio Ichiki, et al.
Published: (2019)

Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression
by: Akash Saggam, et al.
Published: (2022)

Myelosuppression Rates with Administration of Nafcillin with and without Rifampin in Pediatric Patients
by: Jolly Kuriakose, et al.
Published: (2022)

The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma
by: Judith A. E. M. Zecha, et al.
Published: (2022)

The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials
by: Jingyue Qiu, et al.
Published: (2023)

A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer
by: Kyemyung Park, et al.
Published: (2022)

Aggressive CD4-CD8-CD45RA+CCR10- Primary Cutaneous Peripheral T-cell Lymphoma, Not Otherwise Specified: A Case Report
by: Natsumi Ikumi, et al.
Published: (2019)

Oral microbial changes, oral mucositis and febrile neutropenia during myelosuppressive chemotherapy in patients diagnosed with a solid tumor or lymphoma
by: Judith A. E. M. Zecha, et al.
Published: (2024)

Mental and physical health characteristics of older and younger adults receiving medication for opioid use disorder
by: Teresa J. Walker, et al.
Published: (2024)

Pharmacometabolomic prediction of individual differences of gastrointestinal toxicity complicating myelosuppression in rats induced by irinotecan
by: Yiqiao Gao, et al.
Published: (2019)

Model‐based approach to identify predictors of paclitaxel‐induced myelosuppression in "real‐world" administration
by: Ahmed M. Salem, et al.
Published: (2023)

Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
by: Kanyarat Khaeso, et al.
Published: (2021)

A Case of Azathioprine Induced Severe Myelosuppression and Alopecia Totalis in IgA Nephropathy
by: Jae Choon Kim, et al.
Published: (2017)

Transcriptome Profiling Analysis Reveals the Potential Mechanisms of Three Bioactive Ingredients of Fufang E'jiao Jiang During Chemotherapy-Induced Myelosuppression in Mice
by: Xue Li, et al.
Published: (2018)

Evaluation of The Effect of Fisetin against Cyclophosphamide-Induced Myelosuppression and Oxidative Stress in Male Albino Rats
by: Amani Jabbar, et al.
Published: (2023)

Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide
by: He Zhang, et al.
Published: (2022)

Pharmacological Role of (Forssk.) Edgew in Preventing Cyclophosphamide-induced Myelosuppression and Modulating Innate and Adaptive Immune Response
by: Hafiz Muhammad Farhan Rasheed, et al.
Published: (2022)

Evaluation of the Possible Immuno-Protective Effect of Nigella Sativa Seed Oil on Cyclophosphamide- Induced Myelosuppression in Mice
by: Shahad A. Alsaad, et al.
Published: (2020)

Blood-supplementing effect of low molecular weight peptides of E-Jiao on chemotherapy-induced myelosuppression: evaluation of pharmacological activity and identification of bioactive peptides released in vivo
by: Jinju Zhang, et al.
Published: (2024)

The Younger Set
by: Chambers, Robert W. (Robert William), 1865-1933

Exploration of the Active Component and Mechanisms of Shengyu Decoction Against Myelosuppression Using Network Pharmacology and in vitro Experimental Validation
by: Ma B, et al.
Published: (2024)

Danggui Buxue decoction alleviates cyclophosphamide-induced myelosuppression by regulating β-hydroxybutyric acid metabolism and suppressing oxidative stress
by: Yiqiao Gao, et al.
Published: (2023)

The Younger American Poets
by: Rittenhouse, Jessie Belle, 1869-1948

Undetected Severe Fetal Myelosuppression following Administration of High-Dose Cytarabine for Acute Myeloid Leukemia: Is More Frequent Surveillance Necessary?
by: Jessica Parrott, et al.
Published: (2017)

Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug delivery
by: Yuxin Chen, et al.
Published: (2022)

Association Between Genetic Polymorphisms of Metabolic Enzymes and Azathioprine-Induced Myelosuppression in 1,419 Chinese Patients: A Retrospective Study
by: Zhao-Yang Chen, et al.
Published: (2021)